EN DE

Hubei Nengte Technology Co (002102) Fair Value & Analysis

Industrials · CN · Market cap 5.4B CNY

HN Hubei Nengte Technology Co 002102 · SHE
Price¥2.24
Fair Value¥1.71
Upside-23.7%
Quality54/100
Watch Hubei Nengte Technology Co for free, get notified when fair value or trend changes. Watch for free
Weak Growth
Thin margins · 0.7% net margin
Low debt · negative free cash flow
Trails peers (2/12)
Narrow moat 27/100
Evidence: Medium Range ¥1.28 – ¥2.13 Share as image

Fair value as of: Jul 25, 2026

From 7 valuation models · updated 16 days ago

Share price −3.9% over the past month.

A solid business, but screening 24% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case (¥2.13). The favourable scenario is already priced in.
  • Solid but not exceptional quality (54/100) and above fair value, neither a clear bargain nor a standout compounder.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

¥4.59 ¥1.55 Fair Value ¥1.71 Feb 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 25, 2026.

How to read this chart

60‑month range ¥1.55 – ¥4.59 · fair‑value band ¥1.28 – ¥2.13 · the ¥2.24 price screens above the ¥1.71 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 25, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Hubei Nengte Technology Co (002102) currently trades at ¥2.24, while our model-based Fair Value estimate is ¥1.71, implying the stock looks roughly 23.7% overvalued today. The Quality Score stands at 54/100 (solid quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).

Over the trailing twelve months, Hubei Nengte Technology Co generated revenue of 6.5B CNY at a net margin of 0.7%. Revenue declined 34.4% year over year. It earns a return on equity of 1.7%. Net debt stands at 75.9M CNY. Fundamentals as of Jul 25, 2026

Our scenario range runs from ¥1.28 (bear case) to ¥2.13 (bull case); at ¥2.24, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 52% below its 52-week high and 4% above its 52-week low, currently below its 200-day average. For context, the median of 10 Industrials peers we cover trades at -14% fair-value upside, at -24%, 002102 screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model BearBaseBull Evidence
Highest evidence
Residual Income ¥1.02 ¥1.09 ¥1.21 76
P/E Multiple ¥1.66 ¥2.21 ¥2.76 63
P/B Multiple ¥1.28 ¥1.71 ¥2.13 55
All 7 models by family
DCF Models
Owner Earnings ¥1.89 ¥3.78 ¥7.62 31
Earnings-Based
Graham-Dodd ¥0.6800 ¥4.76 ¥6.68 54
Lynch FV ¥1.71 ¥2.44 ¥3.17 50
Multiples
P/E Multiple ¥1.66 ¥2.21 ¥2.76 63
P/B Multiple ¥1.28 ¥1.71 ¥2.13 55
Asset-Based
NCAV (Graham) ¥0.6200 ¥0.8300 ¥1.24 50
Economic Profit
Residual Income ¥1.02 ¥1.09 ¥1.21 76

Widest divergence: DCF Models (¥3.78) versus Asset-Based (¥0.8300). Highest evidence: Residual Income (76).

Key figures & financial health

Revenue (TTM) 6.5B CNY
Revenue growth (YoY) -34.4%
Net margin 0.7%
Return on equity 1.7%
Free cash flow −448M CNY FY2025
P/E ratio 110.0
More key figures
Operating margin 2.7%
EPS (TTM) ¥0.0200
EPS growth (YoY) -88.7%
Net debt 75.9M CNY FY2025

Figures from reported company fundamentals · as of Jul 25, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 54/100

Of which business quality 50 · Market factors (momentum, volatility) 25

Profitability 37
Margins and returns on capital today
Quality Growth 41
Are margins and returns improving?
Cashflow 1
Earnings quality: real cash, not paper profit
Fin. Strength 61
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 72
Calm price path (market factor)
Momentum 8
Price trend over the last 3–12 months (market factor)
52W Momentum 2
Distance to the 52-week high (market factor)
Net Issuance 100
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Hubei Nengte Technology Co., Ltd operates an ecommerce platform for the supply chain of plastic raw materials in China. It also engages in the research and development, production, and sale of pharmaceutical intermediates, such as montelukast sodium intermediates, rosuvastatin series intermediates, and vitamin and its intermediates, etc.

Full company description

Hubei Nengte Technology Co., Ltd operates an ecommerce platform for the supply chain of plastic raw materials in China. It also engages in the research and development, production, and sale of pharmaceutical intermediates, such as montelukast sodium intermediates, rosuvastatin series intermediates, and vitamin and its intermediates, etc. In addition, it is involved in the real estate leasing and gold mining activities. The company was formerly known as Guanfu Holding Co., Ltd. HuBei NengTer Technology CO.,Ltd was founded in 1999 and is headquartered in Jingzhou, China.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Hubei Nengte Technology Co reported revenue of ¥7.3B in FY2025 versus ¥13.5B in FY2021, a compound −14.4%/yr. Reported net income was ¥248M in FY2025, compounding +25.2%/yr from FY2021.

Growth Quality 14/100
Revenue growth is weak, negative or inconsistent.
Latest Revenue (FY 2025)
7.3B CNY
Latest YoY
−40.8%
Avg. growth/yr (3Y)
−16.0%
Avg. growth/yr (5Y)
−10.8%
Avg. growth/yr (22Y)
+19.6%
Revenue −14.4%/yr
FY21 ¥13.5B
FY22 ¥12.3B
FY23 ¥11.1B
FY24 ¥12.3B
FY25 ¥7.3B
Net income +25.2%/yr
FY21 ¥101M
FY22 ¥444M
FY23 ¥259M
FY24 −¥588M
FY25 ¥248M

002102 screens 24% overvalued. Compare with CITIC Limited →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Hubei Nengte Technology Co Fair Value". https://www.fairvalue-calculator.com/stock/002102

Peer Group

Conglomerates · 370 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 54 · Above median
Fair Value upside −24% · Below median
Return on equity (TTM) 2% · Below median
Return on assets -0% · Bottom 25%
Net margin (TTM) 1% · Below median
Operating margin (TTM) 3% · Below median
Revenue growth -34% · Bottom 25%
Debt / equity 0.06× · Lower than median

Valuation Multiples vs Conglomerates median · lower = cheaper

P/E (TTM) 110.0× · Pricier than 75% of peers
P/B 1.77× · Pricier than median
P/S (TTM) 0.84× · Pricier than median
EV/EBITDA 36.9× · Pricier than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 2 · sector 21
FUTURE 0 · sector 16
PAST 7 · sector 20
HEALTH 97 · sector 88
DIVIDEND 0 · sector 39

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Conglomerates stocks, each showing price versus our Fair Value estimate (as of Jul 25, 2026).

Stock Price Fair Value vs Fair Value
CITIC Limited 0267 HK$11.28 HK$22.56 +100%
SK Inc 034730 580,000 KRW 497,919 KRW -14%
PT Astra International Tbk, ASII 4,810 IDR 9,620 IDR +100%
The Siam Cement Public Company SCC 254.00 THB 199.40 THB -21%
SRF Limited SRF ₹2,875 ₹1,053 -63%
Empresas Copec S.A COPEC 6,330 CLP 10,879 CLP +72%
Posco International Corporation 047050 50,900 KRW 61,248 KRW +20%
Tube Investments of India Limited TIINDIA ₹2,940 ₹559.30 -81%
Doosan Corporation 000155 464,000 KRW 75,620 KRW -84%
Thermax Limited THERMAX ₹4,809 ₹1,087 -77%

Compare Hubei Nengte Technology Co with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Hubei Nengte Technology Co (002102) overvalued or undervalued?
As of Jul 25, 2026, our model estimates a fair value of ¥1.71 versus a price of ¥2.24, about −24% (overvalued).
What is the fair value of 002102?
Our model-based fair value for Hubei Nengte Technology Co is ¥1.71 (as of Jul 25, 2026), built from audited fundamentals. The current price is ¥2.24.
What is the quality score of 002102?
Hubei Nengte Technology Co has a Quality Score of 54/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Hubei Nengte Technology Co (002102)?
Hubei Nengte Technology Co reported trailing-twelve-month revenue of about 6.5B CNY (latest available figure, as of Jul 25, 2026).
What is the net profit margin of 002102?
The net profit margin of Hubei Nengte Technology Co is about 0.7%, meaning it keeps roughly 0.7% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Hubei Nengte Technology Co and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.